Impax Laboratories Inc
Tiffany Nguyen has over two decades of experience in clinical operations within the pharmaceutical industry, currently serving as the Director of Clinical Operations at Impax Laboratories since 2004. Prior experience includes roles as a Senior Clinical Research Associate at Amylin Pharmaceuticals and Kendle International, as well as a Clinical Research Associate at Quintiles. Tiffany holds a Master of Business Administration from CSUSM College of Business and a Bachelor of Science in Biochemistry and Cell Biology from UC San Diego.
This person is not in any teams
Impax Laboratories Inc
Impax Laboratories, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. Its segments include Impax Generics and Impax Specialty Pharma. The Impax Generics segment is focused on the development, manufacture, sale and distribution of its generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their established drug names. The Impax Specialty Pharma segment is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease, post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.